• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mechanisms and frequency of resistance to temafloxacin.

作者信息

Appelbaum P C

机构信息

Division of Clinical Microbiology, Hershey Medical Center, Pennsylvania 17033.

出版信息

Am J Med. 1991 Dec 30;91(6A):27S-30S. doi: 10.1016/0002-9343(91)90306-i.

DOI:10.1016/0002-9343(91)90306-i
PMID:1662892
Abstract

The bactericidal activity of temafloxacin and other fluoroquinolones is attributed to inhibition of bacterial DNA gyrase (topoisomerase II), an enzyme that regulates supercoiling and uncoiling of DNA. Because of this unique bactericidal mechanism of action, resistance to fluoroquinolones is limited to spontaneous mutations. In vitro studies were conducted to determine the frequency at which spontaneous resistance to temafloxacin occurs and to determine whether cross-resistance to other antimicrobial agents develops. In 13 strains of bacteria, the frequency of spontaneous resistance mutation to concentrations of temafloxacin at four and eight times the minimal inhibitory concentration (MIC) ranged from less than 1 x 10(-10) to 1.4 x 10(-7). Temafloxacin demonstrated a lower frequency of resistance to both methicillin-resistant and methicillin-sensitive Staphylococcus aureus compared with ciprofloxacin and ofloxacin. Cross resistance with other fluoroquinolones was observed.

摘要

相似文献

1
Mechanisms and frequency of resistance to temafloxacin.
Am J Med. 1991 Dec 30;91(6A):27S-30S. doi: 10.1016/0002-9343(91)90306-i.
2
In vitro activity of temafloxacin against gram-positive cocci including methicillin-resistant Staphylococcus aureus.替马沙星对包括耐甲氧西林金黄色葡萄球菌在内的革兰氏阳性球菌的体外活性。
Am J Med. 1991 Dec 30;91(6A):15S-18S. doi: 10.1016/0002-9343(91)90303-f.
3
Evaluation of the bactericidal activity of temafloxacin.替马沙星杀菌活性的评估。
Am J Med. 1991 Dec 30;91(6A):31S-34S. doi: 10.1016/0002-9343(91)90307-j.
4
Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacin.对临床可达到的环丙沙星和替马沙星浓度具有抗性的自发产生的葡萄球菌突变体。
Eur J Clin Microbiol Infect Dis. 1992 Mar;11(3):243-6. doi: 10.1007/BF02098088.
5
Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.近期临床分离株对替马沙星(A-63004)及其他抗菌药物的敏感性。
Drugs Exp Clin Res. 1992;18(8):311-7.
6
[In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].[普卢利沙星的活性代谢产物NM394对金黄色葡萄球菌、大肠杆菌和铜绿假单胞菌的体外短期杀菌活性及蓄积作用:与环丙沙星、左氧氟沙星和加替沙星的比较]
Jpn J Antibiot. 2002 Dec;55(6):791-9.
7
In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.司帕沙星及其他三种氟喹诺酮类药物对耐甲氧西林金黄色葡萄球菌和表皮葡萄球菌的体外活性
Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):55-8. doi: 10.1007/BF01971273.
8
Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
J Antimicrob Chemother. 1991 Nov;28(5):695-9. doi: 10.1093/jac/28.5.695.
9
Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition.临床分离株中喹诺酮耐药机制:司帕沙星及不同疏水性氟喹诺酮类药物的蓄积,以及膜成分分析。
J Antimicrob Chemother. 1993 Sep;32(3):379-92. doi: 10.1093/jac/32.3.379.
10
In-vitro activity of temafloxacin for gram-positive pathogens.替马沙星对革兰氏阳性病原体的体外活性。
J Antimicrob Chemother. 1991 Dec;28 Suppl C:9-14. doi: 10.1093/jac/28.suppl_c.9.

引用本文的文献

1
Cloning of multidrug resistance gene pqrA from Proteus vulgaris.普通变形杆菌多药耐药基因pqrA的克隆
Antimicrob Agents Chemother. 1995 Feb;39(2):453-7. doi: 10.1128/AAC.39.2.453.